WuXi PharmaTech Starts Construction of $150 Million Biologics Facility

WuXi PharmaTech, through its subsidiary WuXi Biologics, began construction of its $150 million biologics manufacturing facility in Wuxi city. The facility is slated to be the world's largest mammalian cell culture facility using disposable bioreactors. It will also be the largest biologics manufacturing plant in China of any type. WuXi already provides biologic drug manufacturing services for both clinical and commercial use; the new facility will add to its commercial capacity. More details.... Stock Symbols: (NYSE: WX) Share this with colleagues: // //